A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of Aripiprazole in the Treatment of Patients With Bipolar I Disorder With a Major Depressive Episode.
Withdrawn prior to enrolment
Phase of Trial: Phase III
Latest Information Update: 07 Nov 2013
At a glance
- Drugs Aripiprazole (Primary)
- Indications Bipolar I disorders
- Focus Therapeutic Use
- Sponsors Bristol-Myers Squibb; Otsuka Pharmaceutical Development & Commercialization
- 29 Dec 2006 Status change
- 24 Feb 2006 New trial record.